News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Corey Pelletier

Articles by Corey Pelletier

96 Elacestrant Real-World Progression-Free Survival of Adult Patients With ER+/HER2–, Advanced Breast Cancer: A Retrospective Analysis Using Insurance Claims in the United States

ByElyse Swallow,Jessica Maitland,Kirthana Sarathy,Ellen Sears,Yasir Nagarwala,Janelle DePalantino,Eric Kruep,Corey Pelletier,Sebastian Kloss,Tomer Wasserman

April 18th 2025

37 Estimating the Direct and Indirect Resource Burden of Treatment Management With Current Standard of Care or Elacestrant for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer Patients: A Population- Level Provider Model

37 Estimating the Direct and Indirect Resource Burden of Treatment Management With Current Standard of Care or Elacestrant for ER+, HER2–, ESR1-Mutated Advanced or Metastatic Breast Cancer Patients: A Population- Level Provider Model

ByGregory Vidal, MD, PhD,Frank Cinfio,Jack Badaracco,Corey Pelletier,Matthew Gitlin

June 22nd 2024

Latest Updated Articles

Trending on CancerNetwork

FDA Approves RP1/Nivolumab for Progression on Anti–PD-1 Therapy in Melanoma

The Lowest-Ever Hazard Ratio in Multiple Myeloma Bispecific Trials?

Why Earlier CAR T-Cell Therapy May Benefit Patients With Multiple Myeloma

GLP-1 Receptor Agonists and Cancer: Renewed Momentum for Metabo-Oncology

What Does an End-of-Life Doula Do for Patients With Cancer?